Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I take all the communication with DI posted on this board with a grain of salt, but he has mentioned, in almost every communication, that they purposely did not give any guidance regarding timelines in the DL PR. I will take that as clear communication from management that any prior timeline guidance should be disregarded.
Big fan, Sir P, but now you are taking Covid advice from a dude getting paid minimum wage to post baseless claims on this board 15 times a day while sitting on a folding chair in his parents basement!
There was no timeline guidance mentioned in the DL lock. All the guidance was in PR’s prior to that and any reliance on those is in my opinion not valid.
On a folding chair in his parents basement.
I agree that in a lot of ways the business world is completely rigged.
But we haven’t heard what their excuse is yet. So once they come out with the reason for being late we can assess whether it’s truthful or whether they are telling us a fib.
"This may become very important as mutations in SARS-CoV-2 that could limit a vaccine or treatment induced protection have already been reported."
Not seen anything factual to back this up at this time. There have been speculations, but so far none of the mutating strains of the virus has proven not to be protected by the vaccine. There's currently many trials going on regarding various mutations, but they have all been within the current first two approved vaccines protection.
I agree that it is a problem if information is shared with a few people and not everyone. I have not seen factual examples of this. I have seen people interpreting other posts on this board to fit into their own narrative. I have seen people taking the timeline issued by management this summer and trying to say it should be the same timeline post DL, though management did not give a timeline in the DL PR. I have seen people using timelines from BP, though NWBO neither have the funds nor staffing resources to get things done in the same time.
I. myself, have succumbed to putting too much reliance on various posts and that has had me go on an emotional rollercoaster, which in retrospect was completely foolish of me.
I understand that people have different timelines for their investments. I, personally, would have like to realize some gains this year in my portfolio. Not because I think the tax rate will change next year, but because it would fit my financial situation to take some gains now and not the next few years, due to some other realizations that will take place over the next few years. I would have sold 12/31/20, only to buy back 1/4/21, so that the tax event for some of my shares would be this year and my future tax burden would have been much less. I unfortunately understand that this could possibly not happen, though still hopeful we get news and a rise in the SP prior to 2021. I will still do it, but it will not be as effective at $1.30 as it would have been at $4-5.
I am not dismissing anything. I am simply saying that how can we hold someone accountable for something we have no info about.
I also want as much transparency as possible. I have been the CEO and on the board of a publicly traded company and I know how frustrating it can be on the other side, not being able to communicate without giving away information not yet in the public domain. My company was a gaming platform and if you know anything about that industry, you will know that there's very aggressive message boards in that industry. Many forum's discussing the various poker software and similar for sports betting and casino. Not being able to quell rumors is very hard, when you can see how these rumors affect your daily revenue. I had many meeting with our outside corporate securities counsel regarding PR's I wanted to issue but was not allowed to.
You even say that there are a few ways that could justify the delay!!! Why not withhold judgement until we know if those are the reason for the delay, then?
I understand that this is frustrating to all of us. I can't fathom how this is not yet filed. I will, however, withhold my judgement until I see the reason for not filing and whether they were in a position where filing would open them up to legal liability.
I am not sure I understand what a post from another poster has to do with what is actually going on. I appreciate all that Senti is posting, but I also take posts on a message board with a grain of salt. We were told that it was virtually a done deal that the warrants would be further suspended. I appreciate your post, Flipper, but I just think people put too much into what other people are posting.
We all want the same thing and YES it is extremely frustrating that some of us, my self included, have had expectations regarding timing of TLD that was not based in reality. Once they locked Data, they have not issued any timeline guidance. They have not said anything about when they expected this to be ready. I understand that before DL, they had some hopes of the time it would take, and I understand that a lot of people are using those timelines to project TLD much sooner than what we are facing. Just understand that those guidelines were not issued by company post DL.
I doubt anyone on this board do not want accountability. Some are just waiting to see what happens before passing judgement. We all want to know what is happening. Once we get the information, we can make up our minds if we feel they did not tell us things they should or if they were justified in holding on to the information.
I am not sure what we should hold them accountable for when we don't know what they are doing. You can't hold them accountable for something you feel should be happening, as you really don't know what is going on.
I would love to get some updates on Sawston. I am not sure if updating on Sawston would give us any unintentional information that they currently do not want to release.
We live in a very litigious society and I have many friends from law school who are making an absolute killing from shareholder suits.
There's always hope. Without it, life would be horrible. I hope for news every day, the key is to temper your expectations so that when no news appears, it doesn't play with your emotions. After market period is rough on this board, when people air out their frustrations.
Agree that the FDA is playing this passive/aggressive game. I think our legal system has some to do with it, but I also think BP has pushed it that way. It gives an incredible advantage to large companies with sizeable regulatory departments as opposed to smaller companies without the funds and staff to maneuver through this process with so little guidance from FDA during the whole process.
I know that. FDA has nothing to do with that site. "They" in my post refers to NWBO.
I think the reason they have not been able to extend the warrants at this time is that they are unblinded and will have a hard time coming up with a strike price for any additional warrants people have requested to suspend the warrants for any additional period of time. It is virtually impossible to even negotiate a set price when they are in possession of non public information. The only seemingly possibility would be to agree on a strike price based on a rolling average after the information becomes public, and I assume that is not acceptable to the warrant holders.
If they have not yet extended the suspension of the warrants, that means the warrants are currently available to be exercised. It just shows that the warrant holders are friendlies as we have not been 'flooded' with shares for sale as some have predicted. There could be a gentlemen's agreement with the warrant holders that company will act in good faith at a later time, if they do not exercise them at the moment.
I do not know when these warrants expire, but one way of adding some value without diluting the rest of the shareholders and without revealing anything about the non public information (ie Trial results) could be to extend the date of expiration of the warrants in return for a period of suspension.
I also think it is important to note the Thermoo did not say he sensed the company was inexperienced from
his many conversations. He said that based on his many conversations, he didn’t sense that anything else was currently happening.
I agree that it is too easy to just chalk this up to inexperience.
I doubt many small biotech companies would have experience in the situation that is currently in front of NWBO. I similarly doubt that many BP's would be experienced in this situation as well. I think the difference is that BP have so many more resources and staff that they will not have to face some of the delays that NWBO is currently facing due to lack of staffing/resources.
I also agree that it is amazing how little the pandemic is included in the talks here.
Thermoo is right in his assessment that they are taking their time for the good of the long term prospects and making sure they get it right. That is the general idea I have gotten from my personal conversations and conversations posted on this board with DI. I think of all the interpretations of these conversations, it is what DI wants people to know is their number one priority.
I have seen people here equating lack of experience with lack of competence, which is, in my opinion, as far from the truth as possible.
Jack, the clinical trials website is not an FDA website. It is run by the National Library of Medicine. I would imagine that when talks with the FDA has progressed to a stage where they comfortably can assume that the new endpoints will be the criteria for FDA approval, they will change them. They may have to change them prior to that when/if they are closer to publication as some with experience in that field have indicated that most publishers require the endpoint on clinical trials website to be in line with the published articles.
1. You don't need to file an 8-K about extending the exercise of the warrants.
2. You don't need to include ANYTHING that does not relate to 3 quarter financials in the 10-Q. All the events that happened since SEPT. 30, that are not a reflection of anything that happened during the third quarter do not have to be mentioned in the 10-Q for third quarter.
Good luck to all the longs. I will take a break from here. I am a firm believer in the science. I am just as frustrated as the rest of you regarding the lack of communication from management, but I will wait with my judgement until I know what has been going on. My belief is that this is LP's legacy and she is being extra careful with the sensitive time period they are in at the moment. I hope and believe they will get this drug to market and in a speedy and financial beneficial way.
Same everyday after hours.
Don't see anything on any of my brokerage accounts.
That's a great one. Will keep that in mind.
Optional or not, I think we would have heard from company with an 8-K if the options would have been extended. That is just my opinion, but I don't think company would have the doubt about the extension hanging over their heads if the did extend them. The other argument, that they extended but did not file an 8-k, could be a possibility if they thought it would signal something they weren't prepared to do at this time.
Agree completely. The delay is to insure they get it right IMHO.
I find his response that it was not possible to ask the steering committee any questions more interesting. I will venture out and say that it leads me to believe the information is in their hands, which in turn should mean the company is unblinded.
I specifically said it was "not out of the realm of possibility but that is was definitely unfounded, as in not based in facts".
I agree, Karlchen. She is not in this company for money. This is her legacy on the line. She hopes to go down in history as a woman who fought for this company so they can benefit cancer patients for a long time to come. She wouldn't screw up this legacy by doing something stupid or illegal for a few dollars.
Couldn't agree more.
"But any honest retail investor, upon reflecting on NWBO's recent actions, would have to at least entertain the possibility that even if a buyout is presently on the table, LP & co may not be working in retail's best interest."
Some of the brightest people in Neuro Oncology are currently assisting company in creating their messaging, based on the names on the Steering committee and our in-house experts LL and Dr. Ashkan. Management is likely not very involved in most of this except for Dr. Bosch.
When dealing with a long trial and having to establish the markers/trials to use for comparison data, it should be evident that this might take longer than it would have with the old primary endpoint.
I understand the frustration among investors of not knowing what is going on. I am extremely frustrated myself. I just don't believe anyone of us is in any position to cast blame on anyone without knowing what is going on. I have had a brief encounter with DI and he was very polite and forthcoming. (This was before DL and their self-imposed quiet period). He seemed knowledgeable about investor relations and what his duties are as the company's IR person. He is an easy target these days as he is the only contact we have. His frustrations might well be caused by the fact that he is not in any position to answer the emails being directed at him.
His responses to 10B should be taken with a grain of salt, but they did reveal a lot more than what he likely had intended to communicate. I think the frustration could have been the cause and made him less guarded than usual. I, for one, did read the post and come away with more answers than I ever thought I would.
Even if I accepted posters claims on this board that management is incompetent, I think that they currently are surrounded by good and knowledgeable people who, like us, are hoping DCVax will be the answer to cancer patients and thereby benefitting all of us investors too. Let's see how this plays out and if they really are incompetent, I will be the first in line to criticize them.
No longer there, but I like his posts and the one you are referring to might be the one about going on a search and rescue mission.
That LP is not looking out for retail investors.
She might not be looking out for day traders and people with short term investment horizons, as that likely conflicts with the long term plans. As the biggest investor in the company she has the most to gain if company is successful.
I find it comically sad that so many investors have these wild speculations about what is going on. I understand that they are created by the vacuum that is going on currently due to lack of information, but that shouldn't make adults sit in the corner throwing their toys and crying like a baby. Get a grip and relax.
Once we know what is going on, we can all line up and criticize management if we don't agree with the road they have taken. I just don't understand this need to cry like a baby because they are not doing whatever crazy things each of you guys have concocted in your mind as they way it should be done.
It might not be out of the real of possibility, but it is definitely unfounded, as in not based in fact, but purely speculation.
He was told that 'filing an 8-K regarding any extension of the options' was optional.
I sure hope they didn't extend them. I don't think they will have much influence on the SP as they are for most part belonging to long term investors. The ones who did not agree to the last round of extensions have likely already liquidated the shares they need to or are in the process of doing it, according to Pumpernickel.
Please don't think any of these minimum wage FUDsters are in any position to short this stock. The majority of the 20M shorts are probably warrant holders taking a short covering position for some of their warrants, in order to lock in their initial investment or maybe even a small profit. Once TLD is released and if it is positive, they will likely be happy as I am assuming that they are only covering 20-30% of their warrants. They will still make a sizeable profit on their investment.
They have a responsibility of managing the company in the interest of share holders. That doesn't mean they have to satisfy your emotional needs to know everything. That means they have a responsibility to do what they think is in the best interest of the share holders. Taking their time and getting it right is obviously the route they have chosen as they see that as being in the shareholders best interest.
When I see people who are thinking the trial will be positive saying they are waiting for the stock go down 10 cents so they can buy more shares I get a chuckle. If you really think the SP will take off on positive news, those 10 cents should mean nothing. IF it should take off and hit $4-5, getting in at $1.18 vs $1.28 will be quite meaningless. What if it never hits $1.18, then you will miss out on a huge profit. Those kind of statements seem important for day traders and not investors.